September 25, 2017
College Park Marriott / Hyattsville, MD

We are thrilled to collaborate on this remarkable and long overdue initiative which will allow individuals struggling to live with this multifaceted, volatile, and life-altering autoimmune disease to finally be considered a priority and have the opportunity to be included and heard in the lupus drug development process.

Kathleen A. Arntsen
President & CEO, Lupus and Allied Diseases Association; diagnosed with lupus 35 years ago